DOI: 10.24411/2181-0443/2020-10161
СИНДРОМ ЗАДНЕЙ ОБРАТИМОЙ ЭНЦЕФАЛОПАТИИ У ДЕТЕЙ: КЛИНИЧЕСКИЙ СЛУЧАЙ
Гулямова Дурдона Насриддиновна
Ташкентский Институт Усовершенствования Врачей Мухамедов Акмал Асатулла угли
Детский Национальный Медицинский Центр
Синдром задней обратимой энцефалопатии (ЗОЭ) является клинической и рентгенологической явлением. В статье представлены клинические проявления, радиологические признаки, механизмы формирования, течения и исходы данного вида энцефалопатии. Мы представляем случай педиатрического пациента с синдромом задней обратимой энцефалопатии. Отмечено, что клинико-радиологические расстройства при ЗОЭ обусловлены вазогенным отеком головного мозга. Только МРТ головного мозга является информативным методом диагностики ЗОЭ. Подчеркнуто, что своевременная диагностика синдрома и адекватная помощь приводят к купированию возникших клинико-радиологических расстройств и, что первой неотложной помощью являются анализ и устранение причин, вызвавших данный синдром [17].
Ключевые слова: Синдром задней обратимой энцефалопатии, головные боли, эпилепсия, инфаркт, нарушение зрения, вазогенный отек, нейровизуализация.
БОЛАЛАРДА БОШ МИЯ ОРКА СОХАСИНИНГ ТИКЛАНУВЧИ ЭНЦЕФАЛОПАТИЯСИ
Бош мия орка сохасининг тикланувчи энцефалопатияси (МОСТЭ ёки PRES) асаб тизимининг клиник ва радиологик синдроми хисобланади. Биз келтираётган мацолада ушбу синдромнинг клиник симптомлари, радиологик белгилари, келиб чикиш механизми, кечуви педиатрик бемор мисолида изохлаб берилган. Бош мия орка сохасининг тикланувчи энцефалопатиясининг клинико-радиологик белгилари бош миянинг вазоген шиши оцибатида келиб чикади. Хозирда PRES ташхисоти учун асосий информатив усул бу бош мия магнит-резонанс томографияси булиб цолмоцда. ^айд этиб утиш мухимки, уз вацтида цуйилган ташхис ва курсатилган адекват тез ёрдам, яъни синдром келиб чикиши сабабларини аицлаб уларни бартараф этиш мавжуд клинико-радиологик белгилар йуколишига ва бош мия фаолиятининг цайта тикланишига олиб келади [17].
Калит сузлар: Бош мия орца булаги ревресив энцефалопатияси синдроми, бош огриги, эпилепсия, инфаркт, куз уткирлиги пасайиши, вазоген шиш, нейровизуализация.
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME IN CHILDREN: A CASE REPORT
Posterior reversible encephalopathy syndrome (PRES) is a clinical and radiological entity. The article describes the clinical manifestations, radiological signs, possible mechanisms of pathogenesis, course, and outcomes of this type of encephalopathy. We present a case of a pediatric patient with posterior reversible encephalopathy syndrome. It is noted that clinical and radiological disorders in PRES are caused by vasogenic cerebral edema. Only brain MRI is an informative method for diagnosis of the PRES. It was emphasized that timely diagnosis of the PRES and adequate management lead to relief of the clinical and radiological disorders and that the first emergency aid is the estimation and elimination of the causes of the PRES [17].
Key words: Posterior reversible encephalopathy syndrome; PRES; headaches; epilepsy; stroke; visual disturbances; vasogenic edema; diffusion-weighted imaging.
Introduction. In recent decades, when the widespread use of MRI has come into clinical practice, a number of pathological conditions have been identified that often mimic acute disorders of cerebral circulation, among which a special role is played by posterior reversible
leukoencephalopathy syndrome.
Posterior Reversible Encephalopathy Syndrome (PRES) was described at the end of the 20th century. by J. Hinchey et al. [1,9,10]. Posterior reversible encephalopathy syndrome (PRES) is a clinical and radiological entity that causes reversible subcortical vasogenic edema, predominantly in the parieto-occipital areas [8,15,20,22].
The clinical course of PRES develops acute or subacutely, in the period of several hours to several days [1,4,19]. Classical manifestations of PRES are severe headache, nausea, vomiting, impaired consciousness, seizure, and visual disturbances that develop on the background of increased blood pressure [12, 21]. Impaired consciousness ranges from mild confusion, stupor, or even coma. The clinical symptoms of this syndrome are often non-specific, so the diagnosis can be difficult to establish.
Numerous literature data indicate that PRES usually occurs between the ages of 20 and 50 (42-45 years) [5], although some authors consider the syndrome to appear at any age (even from early childhood to senile ages) [6].
Case Report. We present a clinical example, which for the first time in our practice was confirmed by a typical picture of changes in MRI scan, described in foreign literature as manifestations of posterior reversible encephalopathy syndrome.
A 7-year-old boy was admitted to a local hospital complaining of headache, nausea, dizziness and seizure that had progressed over 1 week. His history included until 7 years was considered healthy child. From the anamnesis, the child suffered from upper respiratory infection two weeks ago. A week ago, at school, the boy became ill: severe headache, nausea, gait disturbances and decreased visual acuity. Five days later, the child had seizure, generalized tonic convulsions with focal onset.
Upon admission to the hospital, the patient had altered consciousness and makes poor contact. His blood pressure was 130/80 mmHg. And the patient was hospitalized with a diagnosis of "Somatoform autonomic dystonia with the hypertonic type". In the first hours of stay in the department, the condition worsened, as progressing of neurological symptoms, repeated convulsions, lethargy. In neurological status: horizontal nystagmus, flattening of the left nasolabial fold, deviation of the tongue to the right. On the left side, there was an increased tendon reflex and a positive sign of Babinski.
Laboratory investigations were without any significant abnormalities. The examination by ophthalmoscopy does not show any changes of the eye fundus. EEG report: Interhemispheric asymmetry, there are diffuse slow waves predominantly over left parieto-occipital areas. Encephalopathy of the posterior left quadrants. MRI (figure1) report: Signs of pathological intensity of the cortex and subcortical sections of the fronto-parieto-occipital regions, extended intracerebral areas, of both cerebral hemispheres and left cerebellar hemisphere, high-likely PRES.
' *
/ff
* А
* I Ь.
Figurel: MRI findings of the present case (see text).
He was transferred to the intensive care unit with immediate initiation of intravenous Magnesium Sulfate (30mg/kg/day), Midazolam (0.15mg/kg/once), and
antihypertensive (Enalapril 5mg/day) and diuretic (Acetazolamide 10mg/kg/day) therapy. The neurological symptoms rapidly improved by therapy, four days later. Blood pressure decreased to normal ranges and general cerebral and focal symptoms almost disappeared by the 10th day after management. He was discharged without any specific treatment.
Discussion. This complex of symptoms is called posterior reversible encephalopathy syndrome, or reversible posterior leukoencephalopathy
syndrome (RPLS) in English literature. In the Russian-language literature, this name is translated as "posterior reversible encephalopathy" (PRE) [2]. Also, the terms "hypertensive encephalopathy" and "reversible posterior cerebral edema syndrome" are used to describe the syndrome [3,18].
Currently, there are two theories of the pathogenesis of radiological changes in PRES. According to the first, earlier theory, cerebral vasospasm, which occurs in response to a sudden increase in systemic blood pressure, leads to swelling of the brain substance mainly in the region of adjacent zones of blood circulation [7]. A more recent theory, second, is based on the results of studying diffusion-weighted images: increased systemic blood pressure disrupts the autoregulation of cerebral blood flow, causing brain hyperperfusion and passive stretching of cerebral arterioles with subsequent interstitial fluid extravasation and the development of local parenchymal hydrostatic edema [4,16].
The main clinical sign is a headache -bilateral and diffuse, although in some cases it can be localized in the occipital region. Headache can be combined with other symptoms - nausea, vomiting, diplopia, increased blood pressure and photosensitivity. A minority has less intense or subacute headaches, and very rarely there are no headaches.
Epileptic seizures often develop at the onset of the disease and almost always represent secondary generalized tonic-clonic seizures, which are often preceded by an aura in the form of visual hallucinations [14]. Epileptic paroxysms in PRES can be non-convulsive and therefore are often skipped by medical personal in the absence of appropriate alertness and EEG control. The presence of non-convulsive status epilepticus should be considered if the patient retains a changed consciousness for a long time, which may be mistaken for postictal drowsiness or confusion.
In some cases, focal neurological symptoms can occur up to the development of deep paresis, gross sensitive disorders, and discoordination disorders. When examining with fundoscopy, pathology is usually not detected. Repeated episodes of PRES are rare.
As we mentioned above, PRES is a reversible subcortical vasogenic edema, predominantly in the parieto-occipital areas, however, it should be noted that the term "posterior" is not represented the only exact location of the process, since the cortex, frontal lobes, basal ganglia, and the brainstem may also be involved. This unique syndrome is characterized by reversible leukoencephalopathy, in the absence of significant destruction of the white matter. But PRES is a potentially life-threatening neurological syndrome and, in the absence of timely treatment, can be complicated by the development of massive cerebral stroke, its early diagnosis, which determines the correct treatment of patients, is especially important.
In most cases, this syndrome is often mistakenly regarded as a bilateral stroke in the territory of the posterior cerebral arteries due to embolic occlusion of the distal main artery,
which entails inadequate treatment and, accordingly, further an unfavorable prognosis for the patient.
PRES is not an independent nosological unit but simultaneously serves as a full clinical and radiological syndrome.
In our case, the diagnosis was more complicated and was made on the basis of clinical signs, the course of the disease, and neuroimaging. In our patient, the lesions were symmetrically in both hemispheres with the predominant involvement of the parieto-occipital region of the brain.
Neuroimaging changes in this pathology have a characteristic pattern and therefore can become the key to making a diagnosis. If its suspected that the presence of PRES, it is desirable to obtain MRI scan diffusion-weighted images, which is necessary for differential diagnosis such as cerebral edema (vasogenic or cytotoxic). An increase in the signal in diffusion-weighted images indicates the formation of cerebral stroke with PRES. As the MRI visualization of the brain becomes more accessible, PRES becomes more recognizable, and its frequency of detection increases.
Conclusion. An analysis of a neurological study conducted by this case allows us to conclude that only brain MRI is an informative method, which identifies characteristic changes in white matter and excludes diseases that resemble clinical manifestations (neoplasms, demyelinating diseases, cerebrovascular disorders).
Early and correct diagnosis of the syndrome of posterior reversible encephalopathy is important due to the fact that timely initiated antihypertensive and anti-edematous therapy contributes to the complete reverse development of clinical and radiological signs.
REFERENCES
1. V.V. Gudkova, E.I. Kimelfeld, L.V. Stakhovskaya. A rare syndrome of posterior reversible encephalopathy requiring emergency care. Russian National Research Medical University named after N.I. Pirogova. Consilium Medicum. 2018; 20 (2): 84-89
2. O.I. Yaroshevskaya, O.E. Gurevich, I.M. Drozdova, P.S. Rogatkin. The reversible encephalopathy in children with acute post-streptococcal glomerulonephritis. N.I. Pirogov. Journal of Pediatrics, Russia, 2015/№ 3
3. V.I.Skvortsova, L.V. Gubsky, E.A. Melnikova. Syndrome of posterior reversible encephalopathy. Journal of Neurology and Psychiatry, 5, 2010 page 104-109
4. E.I. Bogdanov, I.A. Khasanov, H.I. Mamedov, D.M. Khasanova. Differential diagnosis of the syndrome of posterior reversible leukoencephalopathy and heart attacks in the territory of the posterior cerebral arteries. Actual problems of medicine. Volume 1, 2012
5. R. Miller, R. Shivashankar, M. Mossa-Basha and D. Gandhi. Reversible cerebral vasoconstrictor syndrome. Part 1: epidemiology, pathogenesis, clinical course. American Journal of Neuroradiology. August 2015
6. Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. 2017; doi:10.1007/s00415-016-8377-8
7. Lamy C, Oppenheim C, Mas JL. Posterior reversible encephalopathy syndrome. 2014;121:1687-701. doi:10.1016/B978-0-7020-4088-7.00109-7.
8. Tadashi Ozawa et al. Unilateral posterior reversible encephalopathy syndrome: A case report. doi.org/10.1016/j.clineuro.2019.105493
9. J. Hinchey, C. Chaves, B. Appignani, J. Breen, L. Pao, A. Wang, et al., A reversible posterior leukoencephalopathy syndrome, New England Journal of Medicine. 334 (1996)
10. Sencan Acar. Posterior Reversible Encephalopathy Syndrome in a Five-Year-Old Child: A Case Report. doi.org/10.1016/j.transproceed.2019.01.186
11. Syuichi Tetsuka. Posterior reversible encephalopathy syndrome: A review with emphasis on neuroimaging characteristics doi.org/10.1016/j.jns.2019.07.018
12. Sergio Racchiusa. Posterior reversible encephalopathy syndrome (PRES) and infection: a systematic review of the literature doi.org/10.1007/s10072-018-3651-4
13. Zheng X, Liu X, Wang Y, Zhao R, Qu L, Pei H, Tuo M, Zhang Y, Song Y, Ji X, Li H, Tang L, Yin X (2018) Acute intermittent porphyria presenting with seizures and posterior reversible encephalopathy syndrome: two case reports and a literature review. Medicine. doi.org/10.1097/MD.0000000000011665
14. K.Heo, K.H. Cho, M.K. Lee, et al., Development of epilepsy after posterior reversible encephalopathy syndrome, Seizure. doi:10.1016/j.seizure.2015.12.005
15. Sudulagunta SR, Sodalagunta MB, Kumbhat M, Settikere Nataraju A. Posterior reversible encephalopathy syndrome (PRES). Oxf Med Case Reports 2017; doi:10.1093/omcr/omx011
16. Nightingale S, Wood C, Ainsworth J (2012) The posterior reversible encephalopathy syndrome in HIV infection. BMJ. doi.org/10.1136/bcr.01.2012.5647
17. T.G. Liman, E. Siebert, M. Endres, Posterior reversible encephalopathy syndrome, Current Opinion Neurology. 32 (2019), doi:10.1097/Wm.0000000000000640
18. Floeter AE, Patel A, TranM, Chamberlain MC, Hendrie PC, Gopal AK, Cassaday RD (2017) Posterior reversible encephalopathy syndrome associated with dose-adjusted EPOCH Chemotherapy.17(4):225-230. doi.org/10.1016/j.clml.2016.12.004
19. Zewde Yared. Posterior Reversible Encephalopathy Syndrome: Three Ethiopian Hypertensive Patients Presented with Recurrent Seizure: Case Series and Literature Review. doi:10.4314/ejhs.v29i4.14
20. Chenchen Liu. Isolated Brainstem Involvement in Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature. doi:10.1080/00207454.2018.1561452
21. Grillo Carvalho. Reversible Posterior Encephalopathy Syndrome in a 10-year-old ChildEve doi:10.1590/2175-8239-JBN-2018-0111
22. Hiroshi Ninomiya. Immunoglobulin A Vasculitis Complicated with Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome. doi:10.1111/ped.13947
23. URAZBAEV I. et al. DEVELOPMENT OF AGROTECHNICAL METHODS AND APPLICATION OF BIOMELIORANT PLANTS IN THE LOWER AREAS OF AMUDARYA //Journal of Critical Reviews. -2020. - Т. 7. - №. 11. - С. 1327-1331.
24. Niyazova Z., Khegay L., Rakhmanov A. EVALUATION OF AN IRRITATING AND ALLERGIZING ACTION OF A BIOPELLICLE FOR THE TREATMENT OF PENETRATING EYE INJURIES //Journal of Critical Reviews. - 2020. - Т. 7. - №. 11. - С. 1321-1326.
25. Салахиддинов К. З. и др. Раневые покрытия-как эффективный метод лечения ожоговых ран.
26. Zebiniso N. et al. FEATURES OF PSYCHOLOGICAL REHABILITATION IN PATIENTS WITH EYE INJURIES.
27. Сыдиков А. А. и др. РЕЗУЛЬТАТЫ ПАТОМОРФОЛОГИЧЕСКОЙ ОЦЕНКИ ЭФФЕКТИВНОСТИ ПРИМЕНЕНИЯ ПЛЁНОЧНОГО БИОПОКРЫТИЯ «NOVACEL ZIYO» В ТЕРАПИИ ПРОНИКАЮЩИХ РАНЕНИЙ ГЛАЗ //Re-health journal. - 2020. - №. 3-2 (7).